Teva Pharmaceutical Industries Ltd. ADR-0.93% $19.32B ...

Top 10 Square Logos: Iconic Design in a Box Have you ever wondered why some logos are so memorable even though they’re just a simple square? There’s a reason for that. Square logos were designed to ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Morgan Stanley initiated coverage of GSK (GSK) with an Equal Weight rating and 1,450 GBp price target The shares trade at an inexpensive valuation but the company’s mid- to longer-term growth ...

Bearish flow noted in GSK (GSK) Pharma with 2,330 puts trading, or 1.1x expected. Most active are 2/14 weekly 36 puts and 2/28 weekly 36 puts, with total volume in those strikes near 1,600 contracts.

GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal. The status has been ...

Now, GSK is ready to play catch-up after nabbing its own FDA approval. The FDA approved the British drugmaker's Penmenvy vaccine to protect people ages 10 to 25 against meningococcal serogroups A ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Feb 15 (Reuters) - The U.S. Food and Drug Administration approved British drugmaker GSK's (GSK.L), opens new tab combination vaccine to protect against meningococcal infection for use in people ...